Originally doing business as Medichem Research Inc , MediChem Life Sciences, Inc. (ASDA: MCLS) offered integrated research and development capabilities to pharmaceutical, and biotechnology companies in the following principal areas: proteomics; combinatorial chemistry; computational chemistry; medicinal chemistry; biocatalysis; analytical and separations chemistry; and chemical synthesis process development and scale up, the design and selection of the optimal chemical processes. To support its growth, Medichem acquired firms including some that were themselves SBIR involved: Emerald BioStructures Inc and ThermoGen, In March 2002, the firm was acquired by deCode Genetics (Iceland). As a foreign owned entity, except for completion of awards already in place, the firm was no longer SBIR eligible. In January 2010, deCODE genetics Inc. and changed its name to DGI Resolution, Inc. - then in December 10, 2012, DGI Resolution, Inc. was acquired by Amgen Inc. - itselg having been SBIR involved as a very young start-up
